ev3 Inc.
4600 Nathan Lane North
Plymouth
Minnesota
55442
United States
Tel: 763-398-7000
Fax: 763-398-7200
Website: http://www.ev3.net/
110 articles about ev3 Inc.
-
ev3 Inc. Wins FDA Approval For Carotid Stent
1/25/2007
-
ev3 Inc. Reports 41% Net Sales Increase For Fourth Quarter
1/8/2007
-
ev3 Inc. And FoxHollow Technologies Announce A Clinical Collaboration And Distribution Agreement For SpideRX(R) And RockHawk(R) Technologies
1/8/2007
-
ev3 Inc. To Present At The JPMorgan 25th Annual Healthcare Conference On January 8
1/2/2007
-
ev3 Inc. Issues Durability Guarantee For its EverFlex(TM) Self-Expanding Stents
10/24/2006
-
ev3 Inc. Reports Third Quarter Net Sales Increase Of 55%
10/20/2006
-
ev3 Inc. To Report 2006 Third-Quarter Financial Results And Host Conference Call On October 20, 2006
10/17/2006
-
ev3 Inc. To Present At Upcoming Investor Conferences
9/8/2006
-
ev3 Inc. Reports Second Quarter Net Sales Increase Of 60%
7/28/2006
-
ev3 Inc. To Report 2006 Second-Quarter Financial Results And Host Conference Call On July 28, 2006
7/21/2006
-
ev3 Inc. Establishes $37.5 Million Credit Facility With SVB Silicon Valley Bank
6/28/2006
-
ev3 Inc. Receives FDA Clearance For SpideRX(TM) Embolic Protection Device For Saphenous Vein Graft Angioplasty
6/26/2006
-
ev3 Inc. Reports First Quarter Financial Results
5/2/2006
-
ev3 Inc. To Report 2006 First-Quarter Financial Results And Host Conference Call On May 2, 2006
4/26/2006
-
ev3 Inc. Appoints John K. Bakewell To Board Of Directors; Haywood D. Cochrane Steps Down From The Board
4/6/2006
-
ev3 Inc. Announces Neurovascular Division Management Change
4/3/2006
-
ev3 Inc. Announces Global Launch Of New PROTEGE(R) EverFlex(TM) Self-Expanding Stent System
3/10/2006
-
ev3 Inc. To Present At Lehman Brothers Ninth Annual Global Healthcare Conference Friday, March 10
3/8/2006
-
ev3 Inc. Receives FDA Clearance For SpideRX(TM) Embolic Protection Device For Carotid Artery Stenting
2/20/2006
-
ev3 Inc. Reports Fourth Quarter Financial Results
2/16/2006